Anatoly Chubais is one of the most influential figures in the Russian government. And he's now using his influence to invest billions of dollars in new technology through Rusnano, a move that has benefited a slate of U.S. biotechs, including Bind Biosciences and Selecta Biosciences, which are opening laboratories near Moscow. Bloomberg profiles Chubais and his plans for future investments. Story